The Natasha Clinical Trial launches with a focus on oral immunotherapy to allergens

The Natasha Allergy Research Foundation has announced the launch of its pioneering clinical trial, which hopes to plug the research gap into allergens by proving that everyday foods instead of expensive pharmaceutical drugs can be used as a practical treatment.

The £2.2m oral immunotherapy trial will focus on children and young people with milk and peanut allergies over a course of three years and will be the first major study funded by The Natasha Allergy Research Foundation.

The charity was set up by the parents of Natasha Ednan-Laperouse, who died aged 15 from a severe allergic reaction. The study is currently recruiting 216 people aged between 3 to 23, with one or more allergies to cow’s milk and peanut.  Clinical trials will take place across the country in Leicester, Sheffield, Newcastle, Imperial College London and Southampton.

If successful, participants with ongoing food allergies will be able to live lives where they no longer have to avoid particular food groups that contain small amounts of allergens that, due to factory production lines, could be at risk of cross contamination.

To register your interest in participating in the trial, or to find out more and testimonials, click here.

Subscribe to our newsletter